RecruitingPhase 1NCT07241234

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

Studying Classic phenylketonuria

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Agios Pharmaceuticals, Inc.
Intervention: AG-181(drug)
Enrollment: 20 enrolled
Eligibility: 18-69 years · All sexes
Timeline: 2026 – 2028

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07241234 on ClinicalTrials.gov

Other trials for Classic phenylketonuria

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT07526909
Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Classical Phenylketonuria Patients Undergoing Aerobic and Resistance Exercises
Hacettepe University
ACTIVE NOT RECRUITINGPHASE4NCT06780332
Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq
BioMarin Pharmaceutical
RECRUITINGNANCT01659749
Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria
Emory University

See all trials for Classic phenylketonuria →

← Back to all trials